BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34687281)

  • 1. Risk factors for bleeding hepatocellular adenoma in a United States cohort.
    McDermott C; Ertreo M; Jha R; Ko J; Fernandez S; Desale S; Fishbein T; Satoskar R; Winslow E; Smith C; Hsu CC
    Liver Int; 2022 Jan; 42(1):224-232. PubMed ID: 34687281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of liver adenomatosis: A long-term observational study.
    Barbier L; Nault JC; Dujardin F; Scotto B; Besson M; de Muret A; Bourlier P; Zucman-Rossi J; Salamé E; Bacq Y
    J Hepatol; 2019 Dec; 71(6):1184-1192. PubMed ID: 31419515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular Adenoma Risk Factors of Hemorrhage: Size Is Not the Only Concern!: Single-center Retrospective Experience of 261 Patients.
    Julien C; Le-Bail B; Ouazzani Touhami K; Frulio N; Blanc JF; Adam JP; Laurent C; Balabaud C; Bioulac-Sage P; Chiche L
    Ann Surg; 2021 Nov; 274(5):843-850. PubMed ID: 34334644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular Adenoma Subtypes Based on 2017 Classification System: Exploratory Study of Gadoxetate Disodium-Enhanced MRI Features With Proposal of a Diagnostic Algorithm.
    Tse JR; Felker ER; Cao JJ; Naini BV; Liang T; Lu DSK; Raman SS
    AJR Am J Roentgenol; 2023 Apr; 220(4):539-550. PubMed ID: 36169546
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.
    Nault JC; Couchy G; Balabaud C; Morcrette G; Caruso S; Blanc JF; Bacq Y; Calderaro J; Paradis V; Ramos J; Scoazec JY; Gnemmi V; Sturm N; Guettier C; Fabre M; Savier E; Chiche L; Labrune P; Selves J; Wendum D; Pilati C; Laurent A; De Muret A; Le Bail B; Rebouissou S; Imbeaud S; ; Bioulac-Sage P; Letouzé E; Zucman-Rossi J
    Gastroenterology; 2017 Mar; 152(4):880-894.e6. PubMed ID: 27939373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular adenoma in the paediatric population: Molecular classification and clinical associations.
    Hahn E; Putra J
    World J Gastroenterol; 2020 May; 26(19):2294-2304. PubMed ID: 32476794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-enhanced ultrasound patterns of hepatocellular adenoma: an Italian multicenter experience.
    Garcovich M; Faccia M; Meloni F; Bertolini E; de Sio I; Calabria G; Francica G; Vidili G; Riccardi L; Zocco MA; Ainora ME; Ponziani FR; De Gaetano AM; Gasbarrini A; Rapaccini GL; Pompili M
    J Ultrasound; 2019 Jun; 22(2):157-165. PubMed ID: 30306412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large Hepatic Adenomas and Hepatic Adenomatosis: A Multicenter Study of Risk Factors, Interventions, and Complications.
    Lammert C; Toal E; Mathur K; Khungar V; House M; Roberts LR; Reddy KR; Chalasani N
    Am J Gastroenterol; 2022 Jul; 117(7):1089-1096. PubMed ID: 35333776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular adenomas: review of pathological and molecular features.
    Beaufrère A; Paradis V
    Hum Pathol; 2021 Jun; 112():128-137. PubMed ID: 33307077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New MRI features improve subtype classification of hepatocellular adenoma.
    Bise S; Frulio N; Hocquelet A; Alberti N; Blanc JF; Laurent C; Laumonier H; Balabaud C; Bioulac-Sage P; Trillaud H
    Eur Radiol; 2019 May; 29(5):2436-2447. PubMed ID: 30523457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of contrast-enhanced ultrasound features of hepatocellular adenoma according to different pathological molecular classifications.
    Chen K; Dong Y; Zhang W; Han H; Mao F; Zhang Q; Zheng Z; He W; Wang WP
    Clin Hemorheol Microcirc; 2020; 76(3):391-403. PubMed ID: 32675402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for bleeding in hepatocellular adenoma.
    Bieze M; Phoa SS; Verheij J; van Lienden KP; van Gulik TM
    Br J Surg; 2014 Jun; 101(7):847-55. PubMed ID: 24760723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term Evolution of Hepatocellular Adenomas at MRI Follow-up.
    Vernuccio F; Ronot M; Dioguardi Burgio M; Cauchy F; Choudhury KR; Dokmak S; Soubrane O; Valla D; Zucman-Rossi J; Paradis V; Vilgrain V
    Radiology; 2020 May; 295(2):361-372. PubMed ID: 32181728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unexpected discovery of small HNF1α-inactivated hepatocellular adenoma in pathological specimens from patients resected for liver tumours.
    Balabaud C; Laurent C; Le Bail B; Castain C; Possenti L; Frulio N; Chiche L; Blanc JF; Bioulac-Sage P
    Liver Int; 2018 Jul; 38(7):1273-1279. PubMed ID: 29265678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver biopsy for diagnosis of presumed benign hepatocellular lesions lacking magnetic resonance imaging diagnostic features of focal nodular hyperplasia.
    Sannier A; Cazejust J; Lequoy M; Cervera P; Scatton O; Rosmorduc O; Wendum D
    Liver Int; 2016 Nov; 36(11):1668-1676. PubMed ID: 26969817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions.
    Reizine E; Amaddeo G; Pigneur F; Baranes L; Legou F; Mulé S; Zegai B; Roche V; Laurent A; Rahmouni A; Calderaro J; Luciani A
    Eur Radiol; 2018 Oct; 28(10):4243-4253. PubMed ID: 29721686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gd-EOB-DTPA-enhanced magnetic resonance imaging: differentiation between focal nodular hyperplasia and hepatocellular adenoma].
    Portilha MA; Pedro MT; Ruivo C; Semedo LC; Marques C; Alves FC
    Acta Med Port; 2011 Dec; 24 Suppl 2():531-8. PubMed ID: 22849944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular adenoma: what we know, what we do not know, and why it matters.
    Bioulac-Sage P; Gouw ASH; Balabaud C; Sempoux C
    Histopathology; 2022 May; 80(6):878-897. PubMed ID: 34856012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype-phenotype correlations in hepatocellular adenoma: an update of MRI findings.
    Thomeer MG; E Bröker ME; de Lussanet Q; Biermann K; Dwarkasing RS; de Man R; Ijzermans JN; de Vries M
    Diagn Interv Radiol; 2014; 20(3):193-9. PubMed ID: 24509184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth of hepatocellular adenoma during pregnancy: A prospective study.
    Gaspersz MP; Klompenhouwer AJ; Broker MEE; Thomeer MGJ; van Aalten SM; Steegers E; Terkivatan T; de Koning H; de Man RA; Ijzermans JNM
    J Hepatol; 2020 Jan; 72(1):119-124. PubMed ID: 31550458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.